QOL an important endpoint among patients treated for NSCLC Meeting report 12 February 2013 Pages: 3 - 3
Sibutramine, orlistat not worth it for obesity in the US Clinical study 12 February 2013 Pages: 5 - 5
Antihypertensive drug prescription less likely for Medicare recipients Clinical study 12 February 2013 Pages: 6 - 6
Cholesterol-lowering drug use after MI increasing in the elderly Clinical study 12 February 2013 Pages: 6 - 6
Patients lack understanding of drug therapy in heart failure Clinical study 12 February 2013 Pages: 6 - 6
Esomeprazole a cut above other PPIs in reflux oesophagitis Clinical study 12 February 2013 Pages: 7 - 7
Ciprofloxacin/hydrocortisone warranted for otitis externa in France Clinical study 12 February 2013 Pages: 9 - 9
Lipid-lowering drug prescribing low among South Asian patients in the UK Clinical study 12 February 2013 Pages: 9 - 9
Radiotherapy after mastectomy worth the extra cost in breast cancer Clinical study 12 February 2013 Pages: 9 - 9
H. pylori eradication does not worsen QOL in dyspepsia Clinical study 12 February 2013 Pages: 10 - 10
Infliximab improves QOL in active and fistulising Crohn's disease Clinical study 12 February 2013 Pages: 10 - 10
IV immunoglobulin therapy enhances QOL in stiff-person syndrome Clinical study 12 February 2013 Pages: 10 - 10
Medicare drug costs to remain steep under US house plan Media release 12 February 2013 Pages: 11 - 11
Antihistamine market likely to be upset by OTC loratadine Media release 12 February 2013 Pages: 12 - 12
Wealthy nations accused of dragging their feet, poorer nations suffer News item 12 February 2013 Pages: 12 - 12